These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
740 related articles for article (PubMed ID: 28489822)
21. Disentangling the signaling pathways of mTOR complexes, mTORC1 and mTORC2, as a therapeutic target in glioblastoma. Jhanwar-Uniyal M; Dominguez JF; Mohan AL; Tobias ME; Gandhi CD Adv Biol Regul; 2022 Jan; 83():100854. PubMed ID: 34996736 [TBL] [Abstract][Full Text] [Related]
22. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship. Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692 [TBL] [Abstract][Full Text] [Related]
23. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells. Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608 [TBL] [Abstract][Full Text] [Related]
24. Growing knowledge of the mTOR signaling network. Huang K; Fingar DC Semin Cell Dev Biol; 2014 Dec; 36():79-90. PubMed ID: 25242279 [TBL] [Abstract][Full Text] [Related]
25. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes. Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of mTORC1 by SU6656, the selective Src kinase inhibitor, is not accompanied by activation of Akt/PKB signalling in melanoma cells. Ondrušová L; Réda J; Záková P; Tuháčková Z Folia Biol (Praha); 2013; 59(4):162-7. PubMed ID: 24093774 [TBL] [Abstract][Full Text] [Related]
28. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects. Jhanwar-Uniyal M; Amin AG; Cooper JB; Das K; Schmidt MH; Murali R Adv Biol Regul; 2017 May; 64():39-48. PubMed ID: 28189457 [TBL] [Abstract][Full Text] [Related]
29. DNA-dependent protein kinase catalytic subunit (DNA-PKcs)-SIN1 association mediates ultraviolet B (UVB)-induced Akt Ser-473 phosphorylation and skin cell survival. Tu Y; Ji C; Yang B; Yang Z; Gu H; Lu CC; Wang R; Su ZL; Chen B; Sun WL; Xia JP; Bi ZG; He L Mol Cancer; 2013 Dec; 12(1):172. PubMed ID: 24365180 [TBL] [Abstract][Full Text] [Related]
30. PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. Wang L; Harris TE; Roth RA; Lawrence JC J Biol Chem; 2007 Jul; 282(27):20036-44. PubMed ID: 17510057 [TBL] [Abstract][Full Text] [Related]
31. Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IκB kinase α (IKKα). Dan HC; Ebbs A; Pasparakis M; Van Dyke T; Basseres DS; Baldwin AS J Biol Chem; 2014 Sep; 289(36):25227-40. PubMed ID: 24990947 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of Rb Phosphorylation Leads to mTORC2-Mediated Activation of Akt. Zhang J; Xu K; Liu P; Geng Y; Wang B; Gan W; Guo J; Wu F; Chin YR; Berrios C; Lien EC; Toker A; DeCaprio JA; Sicinski P; Wei W Mol Cell; 2016 Jun; 62(6):929-942. PubMed ID: 27237051 [TBL] [Abstract][Full Text] [Related]
33. The innate immune kinase TBK1 directly increases mTORC2 activity and downstream signaling to Akt. Tooley AS; Kazyken D; Bodur C; Gonzalez IE; Fingar DC J Biol Chem; 2021 Aug; 297(2):100942. PubMed ID: 34245780 [TBL] [Abstract][Full Text] [Related]
34. Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival. Wang Y; Mikhailova M; Bose S; Pan CX; deVere White RW; Ghosh PM Oncogene; 2008 Nov; 27(56):7106-17. PubMed ID: 18776922 [TBL] [Abstract][Full Text] [Related]
35. A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin. Huang Y; Xi Q; Chen Y; Wang J; Peng P; Xia S; Yu S Anticancer Drugs; 2013 Oct; 24(9):889-98. PubMed ID: 23838676 [TBL] [Abstract][Full Text] [Related]
36. Protein kinase N controls a lysosomal lipid switch to facilitate nutrient signalling via mTORC1. Wallroth A; Koch PA; Marat AL; Krause E; Haucke V Nat Cell Biol; 2019 Sep; 21(9):1093-1101. PubMed ID: 31451768 [TBL] [Abstract][Full Text] [Related]
37. Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size. Saci A; Cantley LC; Carpenter CL Mol Cell; 2011 Apr; 42(1):50-61. PubMed ID: 21474067 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of mTORC1 induces loss of E-cadherin through AKT/GSK-3β signaling-mediated upregulation of E-cadherin repressor complexes in non-small cell lung cancer cells. Kim EY; Kim A; Kim SK; Kim HJ; Chang J; Ahn CM; Chang YS Respir Res; 2014 Feb; 15(1):26. PubMed ID: 24571487 [TBL] [Abstract][Full Text] [Related]
39. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells. Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880 [TBL] [Abstract][Full Text] [Related]